HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 120 filers reported holding HOMOLOGY MEDICINES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,854 | -89.1% | 4,356 | -87.4% | 0.00% | – |
| Q1 2023 | $35,485 | -20.6% | 34,453 | -2.9% | 0.00% | – |
| Q4 2022 | $44,706 | -21.6% | 35,482 | -1.8% | 0.00% | – |
| Q3 2022 | $57,000 | -31.3% | 36,118 | -15.6% | 0.00% | – |
| Q2 2022 | $83,000 | -42.8% | 42,814 | -11.4% | 0.00% | – |
| Q1 2022 | $145,000 | -55.5% | 48,301 | -46.3% | 0.00% | -100.0% |
| Q4 2021 | $326,000 | -65.6% | 89,992 | -25.5% | 0.00% | -50.0% |
| Q3 2021 | $949,000 | +10.0% | 120,852 | +1.6% | 0.00% | +100.0% |
| Q2 2021 | $863,000 | +48.8% | 118,967 | +92.2% | 0.00% | 0.0% |
| Q1 2021 | $580,000 | -48.2% | 61,888 | -37.6% | 0.00% | -50.0% |
| Q4 2020 | $1,119,000 | +33.7% | 99,176 | +26.7% | 0.00% | 0.0% |
| Q3 2020 | $837,000 | +19.7% | 78,298 | +69.7% | 0.00% | 0.0% |
| Q2 2020 | $699,000 | +28.5% | 46,131 | +31.7% | 0.00% | +100.0% |
| Q1 2020 | $544,000 | -55.7% | 35,029 | -41.0% | 0.00% | -50.0% |
| Q4 2019 | $1,228,000 | +14.2% | 59,362 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $1,075,000 | – | 59,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $51,211,000 | 17.25% |
| Vida Ventures Advisors, LLC | 770,845 | $8,703,000 | 1.79% |
| AAF Wealth Management, LLC | 59,790 | $675,000 | 0.61% |
| Vivo Capital, LLC | 853,143 | $9,632,000 | 0.43% |
| Bellevue Group AG | 1,737,122 | $19,612,000 | 0.22% |
| PREMIER ASSET MANAGEMENT LLC | 77,108 | $871,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 3,220,293 | $36,357,000 | 0.16% |
| American Investment Services, Inc. | 36,955 | $417,000 | 0.13% |
| Virtus ETF Advisers LLC | 24,646 | $278,000 | 0.12% |
| FIRST MIDWEST BANK TRUST DIVISION | 65,983 | $745,000 | 0.11% |